In the rush to get a chunk of Obama’s healthcare billions, any industry with the slightest idea about remote healthcare is doing their best to claim that they are the rightful recipient of the cash. The latest of these is the CTIA, who recently held a policy forum featuring medical experts and government officials. In it they touted the promise of mobile health applications that would drive down costs and improve the quality of care. They admitted that they didn’t have a policy yet, but they certainly want a chunk of the action for their members when the $19 billion dollar treasure chest is opened. They’re not alone, but amongst all of the feverish lobbying going on in Washington there seems to be a total neglect of the role of the FDA. Instead there’s a general opinion that a good PowerPoint and drinks for enough politicians will overrule any regulatory requirements.
mHealth has been (and still is) a long time in coming. There’s a whole host of reasons for that. It’s trying to grow up in a room full of 800 pound gorillas, amongst them technology, resistance from the medical profession and a lack of standards. But hiding behind the visible 800 pounders is the big brother of invisible gorillas – the Food and Drugs Administration, fondly know as the FDA.
The FDA is responsible for regulating medical devices and services in the U.S. If they say a product or service can’t be offered, then it’s effectively dead. It provides a barrier to entry for manufacturers and services in the medical and health arena. So far, it’s had little to say about many of the visions of the mHealth industry, but there is no doubt that it will. I recently saw a presentation that outlines just how wide its powers and scope are. And they are wide. If the FDA enforced the most aggressive interpretation of its rules it could probably stop sales of the iPhone today.
I’m sure it won’t. This isn’t a rant against the FDA, but about the relative naivety of many of the organisations claiming to offer solutions in their quest for a part of the new healthcare pot. The future of mHealth would be far better served if organisations like the CTIA concentrated less on the high level fanfares and started engaging in informed debate about how the regulatory regime needs to change.